Dogwood Therapeutics, Inc. Other Nonoperating Income (Expense)
Dogwood Therapeutics, Inc. (DWTX) reported Other Nonoperating Income (Expense) of $53.22 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $53.22K, a 54.08% decline year-over-year.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $90.94K.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $57.67K.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $63.07K, a 207.85% increase year-over-year.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was -$6.07M.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was -$122.98K, a 181.49% decline from fiscal 2023.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was $150.90K, a 123.64% increase from fiscal 2022.
- Dogwood Therapeutics, Inc. other nonoperating income (expense) for fiscal 2022 was $67.47K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $53.22K 10-Q · filed 2026-08-14 | $144.17K 10-Q · filed 2026-08-14 | $201.84K derived: sum of 3 quarters · filed 2026-08-14 | $264.91K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $90.94K 10-Q · filed 2026-05-15 | $148.62K derived: sum of 2 quarters · filed 2026-05-15 | $211.69K derived: sum of 3 quarters · filed 2026-05-15 | $327.60K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $57.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $120.74K derived: sum of 2 quarters · filed 2026-03-18 | $236.66K derived: sum of 3 quarters · filed 2026-08-14 | -$6.07M 10-K · filed 2026-03-18 |
| 2025-09-30 | $63.07K 10-Q · filed 2025-11-07 | $178.98K derived: sum of 2 quarters · filed 2026-08-14 | -$6.13M 10-Q · filed 2025-11-07 | -$6.31M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $115.91K 10-Q · filed 2026-08-14 | -$6.19M 10-Q · filed 2026-08-14 | -$6.37M derived: sum of 3 quarters · filed 2026-08-14 | -$6.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.30M 10-Q · filed 2026-05-15 | -$6.49M derived: sum of 2 quarters · filed 2026-05-15 | -$6.47M derived: sum of 3 quarters · filed 2026-05-15 | -$6.45M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$186.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$165.74K derived: sum of 2 quarters · filed 2026-03-18 | -$145.75K derived: sum of 3 quarters · filed 2026-03-18 | -$122.98K 10-K · filed 2026-03-18 |
| 2024-09-30 | $20.49K 10-Q · filed 2025-11-07 | $40.48K derived: sum of 2 quarters · filed 2025-11-07 | $63.24K 10-Q · filed 2025-11-07 | $98.20K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $19.99K 10-Q · filed 2025-08-13 | $42.76K 10-Q · filed 2025-08-13 | $77.71K derived: sum of 3 quarters · filed 2025-08-13 | $116.92K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $22.77K 10-Q · filed 2025-05-09 | $57.72K derived: sum of 2 quarters · filed 2025-05-09 | $96.93K derived: sum of 3 quarters · filed 2025-05-09 | $133.25K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $34.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $74.17K derived: sum of 2 quarters · filed 2025-03-31 | $110.48K derived: sum of 3 quarters · filed 2025-03-31 | $150.90K 10-K · filed 2025-03-31 |
| 2023-09-30 | $39.22K 10-Q · filed 2024-11-08 | $75.53K derived: sum of 2 quarters · filed 2024-11-08 | $115.95K 10-Q · filed 2024-11-08 | $161.11K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $36.31K 10-Q · filed 2024-08-09 | $76.74K 10-Q · filed 2024-08-09 | $121.90K derived: sum of 3 quarters · filed 2024-08-09 | $138.50K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $40.42K 10-Q · filed 2024-05-10 | $85.58K derived: sum of 2 quarters · filed 2024-05-10 | $102.19K derived: sum of 3 quarters · filed 2024-05-10 | $106.99K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $45.16K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-08 | $61.77K derived: sum of 2 quarters · filed 2024-03-08 | $66.57K derived: sum of 3 quarters · filed 2024-03-08 | $67.47K 10-K/A · filed 2024-03-08 |
| 2022-09-30 | $16.61K 10-Q · filed 2023-11-13 | $21.41K derived: sum of 2 quarters · filed 2023-11-13 | $22.32K 10-Q · filed 2023-11-13 | -$301.42K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $4.80K 10-Q · filed 2023-08-11 | $5.71K 10-Q · filed 2023-08-11 | -$318.02K derived: sum of 3 quarters · filed 2023-08-11 | -$316.51K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $906.00 10-Q · filed 2023-05-12 | -$322.83K derived: sum of 2 quarters · filed 2023-05-12 | -$321.32K derived: sum of 3 quarters · filed 2023-05-12 | -$319.82K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$323.73K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$322.22K derived: sum of 2 quarters · filed 2023-03-14 | -$320.73K derived: sum of 3 quarters · filed 2023-03-14 | -$319.33K 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.51K 10-Q · filed 2022-11-14 | $3.00K derived: sum of 2 quarters · filed 2022-11-14 | $4.41K 10-Q · filed 2022-11-14 | -$75.17K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.50K 10-Q · filed 2022-08-12 | $2.90K 10-Q · filed 2022-08-12 | -$76.68K derived: sum of 3 quarters · filed 2022-08-12 | -$137.90K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.40K 10-Q · filed 2022-05-13 | -$78.18K derived: sum of 2 quarters · filed 2022-05-13 | -$139.40K derived: sum of 3 quarters · filed 2022-05-13 | -$255.60K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$79.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$140.79K derived: sum of 2 quarters · filed 2022-03-18 | -$257.00K derived: sum of 3 quarters · filed 2022-03-18 | -$341.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | -$61.22K 10-Q · filed 2021-11-12 | -$177.42K derived: sum of 2 quarters · filed 2021-11-12 | -$261.43K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$116.20K 10-Q · filed 2021-08-13 | -$200.21K 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$84.00K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |